Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fortis Malar HospitalsBOM:523696 -0.92%31 3-Year ROIIC % is -5.67 as of Mar. 2026. GuruFocus rates BOM:523696 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 618 Healthcare Providers & Services companies, Fortis Malar Hospitals ranks worse than 64.72% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Fortis Malar Hospitals's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was -5.67%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Fortis Malar Hospitals's 3-Year ROIIC % or its related term are showing as below:
BOM:523696's 3-Year ROIIC % is ranked worse than 64.72% of 618
companies
in the Healthcare Providers & Services industry
Industry Median: 3.535
vs BOM:523696: -5.67
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Fortis Malar Hospitals 3-Year ROIIC % Related Terms
Fortis Malar Hospitals 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Fortis Malar Hospitals's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:523696 vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Fortis Malar Hospitals's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Malar Hospitals 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Malar Hospitals's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Fortis Malar Hospitals's 3-Year ROIIC % falls into.
Fortis Malar Hospitals's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -13.53523 (Mar. 2026) - -73.057 (Mar. 2023) )
/
( 10.711 (Mar. 2026) - 1061.035 (Mar. 2023) )
=
59.52177
/
-1050.324
=
-5.67%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Fortis Malar Hospitals (BOM:523696) has a 3-Year ROIIC % of -5.67 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Fortis Malar Hospitals and its competitors. According to the industry distribution chart, Fortis Malar Hospitals ranks #400 out of 618 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is Fortis Malar Hospitals' 3-Year ROIIC % too high?
Fortis Malar Hospitals' current 3-Year ROIIC % is -5.67. Based on the distribution chart, Fortis Malar Hospitals ranks #400 out of 618 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fortis Malar Hospitals has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Fortis Malar Hospitals' 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Malar Hospitals ranks #400 out of 618 companies for 3-Year ROIIC %. This places Fortis Malar Hospitals in the lower half of its industry. The industry median 3-Year ROIIC % is 3.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.54, based on 618 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Fortis Malar Hospitals and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Malar Hospitals's current 3-Year ROIIC % is -5.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Malar Hospitals stock overvalued right now?
Fortis Malar Hospitals (BOM:523696) has a current 3-Year ROIIC % of -5.67. The current 3-Year ROIIC % is -5.67. Fortis Malar Hospitals' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Fortis Malar Hospitals (BOM:523696), the current 3-Year ROIIC % is -5.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
31GF Score
Get the complete analysis for BOM:523696
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523696 has been successfully added to your 
